H.R.4812 - Ensuring Compliance Against Drug Diversion Act of 2020116th Congress (2019-2020)
|Sponsor:||Rep. Griffith, H. Morgan [R-VA-9] (Introduced 10/23/2019)|
|Committees:||House - Energy and Commerce; Judiciary | Senate - Judiciary|
|Committee Reports:||H. Rept. 116-584|
|Latest Action:||Senate - 11/18/2020 Received in the Senate and Read twice and referred to the Committee on the Judiciary. (All Actions)|
This bill has the status Passed House
Here are the steps for Status of Legislation:
- Passed House
Summary: H.R.4812 — 116th Congress (2019-2020)All Information (Except Text)
Passed House (11/17/2020)
Ensuring Compliance Against Drug Diversion Act of 2020
This bill provides statutory authority for certain regulations governing the modification, transfer, and termination of a registration to manufacture, distribute, or dispense controlled substances.
It terminates the registration of individuals and entities when they die, cease legal existence, discontinue business, or surrender such registration. It sets forth notification requirements, as well as conditions for transferring or assigning a registration.